Because neurocognitive impairment (NCI) can have deleterious effects on children's ability to function, it is important for clinicians to be able to identify and manage these impairments. In South Africa, differences in treatment guidelines and differential access to antiretroviral treatment (ART) over the past 2 decades have resulted in great variability in disease severity and ART exposure among HIV-infected youth. 1 As a result, a number of adolescents in South Africa would have initiated ART only after immune compromise or after the diagnosis of HIV encephalopathy (HIVE), resulting in neurocognitive deficits that remained permanent despite ART. 1, 2 However, other HIV-infected children have never initiated ART because they are slow progressors who have not yet met current clinical criteria to be eligible for ART. 3 In the adult literature, there is growing understanding of the spectrum of HIV-associated neurocognitive disorders (HAND) and their reduction on ability to function. 4 However, for children, there are still no diagnostic criteria for a spectrum of neurocognitive disorders (ND) secondary to HIV infection. The aim of this study was to apply the HAND criteria for diagnosing NCI in a cohort of HIV-infected youth and to thus establish whether this system was able to detect a spectrum of ND. A secondary outcome was to establish whether the HAND criteria could detect higher rates of major ND in HIVinfected youth with HIVE.
METHODS Standard protocol approvals, registrations, and patient consents. Ethical approval was obtained from the University of Cape Town's Faculty of Health Sciences Human Research Ethics Committee. Informed consent was obtained from parents and children aged 12 and older. Children provided assent at an age-appropriate level.
Participants. From July 2011 until January 2014, 120 youth were recruited for the cross-sectional study. We recruited 86 perinatally HIV-infected youth (aged 6-16 years) from antiretroviral clinics at Groote Schuur Hospital, Red Cross War Memorial Children's Hospital, and community clinics in the Western Cape of South Africa. 5 Neuroimaging data from this cohort have been published. 5 Eligible youth and their parents or guardians were invited to participate. Eligible youth were those who were perinatally infected, had initial and confirmatory HIV tests, and who met the below criteria. Youth on ART were eligible if they were on antiretrovirals for a minimum of 6 months, as we wanted to include youth who were stable on treatment. We also included HIV-infected youth who were asymptomatic slow progressors and ART-naive. 6 Youth who were ART-naive but not slow progressors were not included in the study. A control group of 34 HIV-negative youth, matched to the HIV infected group on age, sex, and ancestry, were recruited from the same schools as the HIV-infected youth to control for risk factors such as socioeconomic status, stressors in the community, and quality of education. 5 Parents/caregivers of the control participants were asked about their HIV status and their response was recorded. Youth with a history of the following were excluded from participation: significant perinatal complications, drug or alcohol exposure during pregnancy; an unstable medical condition; active tuberculosis; an identified CNS condition; a history of traumatic head injury with loss of consciousness, skull fracture; or neurodevelopment disorder other than HIVE. 5 The Beck Youth Inventory and the Conners Parents Rating Scale were used to exclude youth with clinically significant attention-deficit/hyperactivity disorder, depression, or anxiety that may have affected their performance on the neurocognitive battery.
Procedure. HIV-infected youth underwent a full neurologic examination and were assessed for the diagnosis of HIVE by a pediatric neurologist. A diagnosis of HIVE was made on at least one of either of the 2 physical criteria in the 1994 Centers for Disease Control and Prevention diagnostic criteria: (1) acquired microcephaly as measured by sequential head circumference measurements, and (2) acquired symmetrical motor deficits manifested by 2 or more of the following: paresis, pathologic reflexes, ataxia, or gait disturbance. 5, 7 Neurodevelopmental criteria were not used as they may have confounded the neurocognitive assessment. MRI was conducted to exclude concurrent CNS illness, other than HIV infection, that could explain the findings. Blood samples were obtained from clinic records for viral load and CD4 count. Median income by area of residence was used as a measure of socioeconomic status. The median was taken from the City of Cape Town household income census data (2011) for small areas inside the city.
Neurocognitive assessment. Each participant was assessed using a battery of standardized neurocognitive tests commonly used in pediatric neuropsychological assessment and research in South Africa. Tests were administered in the children's home language. Test instructions were translated and back-translated into Xhosa, and we took steps to ensure test administration maintained compliance with International Test Commission guidelines. 8 For large test batteries with age adjustment and normative data, the scaled scores were used in the z score calculation. Scaled scores were calculated according to the normative scores provided in individual test manuals or using the appropriate software. For timed tests and all other tests, the raw scores from control participants were used in the z score calculation. General intellectual functioning was measured using the Wechsler Abbreviated Scale of Intelligence. 9 The Fingertip Tapping subtest from the NEPSY-II (A Developmental Neuropsychological Assessment-Second Edition) 10 and the Grooved Pegboard Test 11 measured psychomotor speed and coordination. Subtests from the Wechsler Intelligence Scale for Children-Fourth Edition (WISC-IV) 12 measured information processing speed. The Rey Complex Figure Test (RCFT) 13 measured visuoconstructional ability. Expressive Language was measured using the Boston Naming Test-South African-short form, category and phonemic fluency. 14 Learning and memory (visual and verbal) were measured using the immediate and delayed recall trials of the RCFT and the Hopkins Verbal Learning Test-Revised. 15 Measures used to assess aspects of executive functioning included the WISC-IV Digit Span Backward subtest, the Color Trails Test 2, and the NEPSY-II Inhibition subtests.
Assessment of functional competence. The Child Behavior
Checklist (CBCL) 16 Total Competence Index required a parent or caregiver to rate the child's competency at completing age-appropriate everyday activities successfully and independently. This instrument is suitable for use in children aged 6 to 18 years and has good crosscultural validity. 17 Higher scores on this scale indicate better functioning. A score of 36 to 40 (borderline range) indicates that the child requires assistance with what should be age-appropriate everyday activities. A score of 35 or less (clinical range) indicates significant impairment in social, school, or other everyday activities.
Statistical analyses. Regarding sociodemographic characteristics,
HIV-infected participants and HIV-negative participants were compared using independent-samples t tests (for continuous variables) and Pearson x 2 test (for categorical variables). In the creation of neurocognitive domains, we set 0.60 as the lower bound of Cronbach a. Composite neurocognitive scores were then created for each domain, using a method described by Ferrett et al. 18 The composite scores for each domain were required to use the American Academy of Neurology (AAN) system for diagnosing HAND. Regarding neurocognitive and adaptive functioning outcome variables, the 2 groups were compared using independent-samples t tests.
Determination of ND status. In 1991, the AAN detailed criteria for defining different levels of HAND. 19 In 2007, a revised classification was proposed that aimed to categorize the presentation of neurocognitive disturbances in the post-HAART (highly active antiretroviral therapy) era. 20 This system proposes 4 categories of HAND in adults: normal, asymptomatic neuropsychological impairment (ANI), mild ND, and HIV-dementia. 20 In the absence of clinically significant functional impairment, the ANI category is used, while the mild ND and HIV-dementia categories are used when functional impairment is mild to moderate or severe. 20, 21 We used scores on the above-mentioned neurocognitive domains, together with an evaluation of functional competence, to classify youth into 1 of 4 HAND categories 20 : no impairment; ANI (diagnosed if the participant scored more than 1 SD below the mean on at least 2 cognitive domains); minor ND (diagnosed if the participant scored more than 1 SD below the mean on at least 2 cognitive domains and had a CBLC Total Competence Index score of #40); and major ND (diagnosed if the participant scored more than 2 SD below the mean on at least 2 cognitive domains and had a CBCL Total Competence Index score of #35).
RESULTS
The 2 groups were well matched on sociodemographic characteristics (see table 1 ).
Compared to a well-matched control group of HIV-negative controls (n 5 34), HIV-infected youth (n 5 86) performed poorly on tests of verbal IQ and Full Scale IQ (see table 2 ). Regarding parental report on the CBCL Total Competence Index, HIVinfected youth showed lower levels of competence in completing age-appropriate, everyday activities.
Eight neurocognitive domains were created; however, 3 of those domains (visuoconstructional ability, cognitive flexibility, and working memory) were each estimated by a single test (Rey-Osterrieth Complex Figure Test -Copy, Color Trails Test Part 2, and Digit Span Backward, respectively) (see table 3 ).
Regarding performance on the neurocognitive test battery, the analyses detected between-group differences (in favor of the HIV-negative controls) in the domains of psychomotor speed and coordination, verbal memory, expressive language, cognitive flexibility, and inhibition (see table 3 ).
Of the 86 HIV-infected youth, 18 youth stable on ART had a clinical diagnosis of HIVE, 45 were stable on ART with no diagnosis of HIVE, and 23 were ART-naive slow progressors (see table 4 ). Using the criteria for HAND, we found that 45.35% of the 86 HIV-infected youth could be diagnosed with an ND (ANI, minor ND, or major ND), 7.14% had a major ND, 32.59% had a minor ND, and 5.81% had ANI. Findings for ART-naive slow progressors (26%) and controls were similar when using the HAND criteria (29%) ( table 4) .
Analysis of the data presented in table 4 investigated the association, within the sample of HIV-infected youth (n 5 86), between being diagnosed with HIVE and presenting with a major ND. Pearson x 2 test of contingency detected a significant association (x 2 1 5 8.15, p 5 0.004, Cramér V 5 0.31). The odds ratio for this analysis was 9.42 (95% confidence interval 5 1.57-56.62), suggesting that those HIV-infected youth with a diagnosis of HIVE were more than 9 times more likely to be observed as experiencing a major ND as those with no clinical diagnosis of HIVE. Current CD4 and viral load was not associated with severity of NCI. In fact, youth with major ND had higher mean CD4 and lower mean viral load than youth from other groups. DISCUSSION The youth included in this study were infected by perinatal transmission of the virus, 22 and infection at this age can have a profound effect on neurocognitive function. HIV-infected youth perform poorly in general cognitive assessments compared to controls, 23, 24 although some studies have found no significant differences between groups. 3, 25 Our neurocognitive battery included a number of tests assessing specific cognitive domains, as global cognitive scores may overlook subtle deficits in one or more domains specific to HIV-infected children.
In keeping with previous studies, HIV-infected children were found to perform significantly poorer in executive function tasks, 24, 25 particularly in cognitive flexibility and inhibition. Poor executive function could lead to significant difficulties with daily activities. 26 HIV-infected youth in this study also had difficulties with processing speed, verbal memory, motor coordination, and expressive language, again in keeping with findings from previous studies. 3, 24, 27 Processing speed has been associated with improved capacity for working memory, reasoning, and accuracy in solving arithmetic word problems, and consistently predicts performance on cognitive tasks. 28 While lower scores on visual-spatial processing and visual memory have been described in HIV-infected children, 29 this study did not find significant impairment compared to HIV-negative controls. As children transition to adolescence, language and reading skills are essential building blocks for literacy and future academic success. 1 There is evidence that language is negatively affected in HIV-infected children, 23, 27, 30 with our study finding significant impairment in expressive language. Poor executive functioning in adolescents having to cope with multiple environmental challenges could translate into significant functional impairment. 26 Previous studies have reported on both subtle NCI in HIV-infected school-age children 25 as well as the presence of HIVE, 31 suggesting a spectrum of ND. Despite the use of ART and improved virologic control with immune reconstitution in this cohort, there are still a significant percentage of youth in this study who were found to have an ND. The prevalence of HIVE has reportedly decreased from 40% to 18% in the post-ART period, 32 suggesting that ART is associated with improved neurocognitive outcomes in children with vertically acquired HIV infection. 32 The HAND criteria were able to detect higher rates of ND in children with a diagnosis of HIVE; higher rates of HAND are to be expected in a group of children who have abnormal neurologic examinations. However, 44.4% of the children with HIVE were found to have no impairment. The diagnosis of HIVE was a clinical diagnosis based on the presence of at least 1 of the 2 physical criteria in the 1994 Centers for Disease Control and Prevention diagnostic criteria. It is possible that although the youth in this group have neurologic impairment, they do not have NCI. As HIVE is an umbrella diagnosis for the disease, damage, or malfunction of the brain caused by HIV, there will remain a group whose overall cognitive performance falls within the normal range despite an abnormal neurologic examination. 7 Diffusion tensor imaging data from this cohort have been published. Youth with HIVE had poor white matter integrity compared to ART-treated children without encephalopathy. 5 It is also possible that either the neurocognitive battery or the assessment of functional competence was not sensitive enough to detect more subtle deficits. It may be that an instrument such as the Vineland Adaptive Behavior Scale, which was not available to the team at the time of this study, is a more accurate measure of adaptive functioning. Current CD4 and viral load was not associated with severity of NCI. In fact, youth with major ND had higher mean CD4 and lower mean viral load than youth from other groups (table 5). Youth with major ND were more likely to have a diagnosis of HIVE. These children have more frequent contact with pediatric neurologic services and have improved adherence because of increased supervision.
Although higher rates of NCI were detected in the HIV-infected group, it is a concern that the HAND Table 2 HIV-infected vs HIV-negative cognitive and behavioral functioning (n 5 120) criteria also found NCI in the negative controls. Of the ART-naive slow progressors, who receive little attention from health services, 26.09% were found to have an ND. Significant motor and cognitive deficits have previously been found in HIV-infected, ART-naive Ugandan children with CD4 cell counts of .350 cells/mL. 24 The ART-naive/slow progressors group differed little from the control group. A possible reason for these findings is that controls were recruited from families with low socioeconomic status. A large number of youth living in sub-Saharan Africa are not fulfilling their developmental potential. Many of these youth are exposed to multiple risks that may include poverty, malnutrition, poor health, compromised caregiving, and unstimulating home environments, which detrimentally affect their cognitive, motor, emotional, and social development. 33 One review of early childhood development in lowand middle-income countries estimates that 15.7% of children are significantly delayed in their cognitive development. 34 Parents/caregivers of the control participants were asked about their HIV status and their response recorded. Two of the parents of the controls reported when contacted that they were HIVinfected. HIV-uninfected youth born to HIVinfected mothers may exhibit differences in neurocognitive function compared to controls whose lives have not been affected by HIV. This could occur because of exposure to HIV and ART in utero and perinatally or the effect of having chronic stigmatizing illness in the environment in which they are raised. 35 The neurologic and neurocognitive profile of HIV disease in youth has been considered to be distinct from the course of the disease in adults, and it may be that NCI in youth should be profiled differently. However, similar cognitive domains have been affected in South African HIV-infected adults. 21 The application of a HAND model of HIV disease, developed with adult HIV/AIDS, to perinatal HIV disease in youth may not be ideal despite the AAN approval for such a model. However, this study serves as a starting point for this conversation. The importance of identifying a spectrum of NCI is valid in a low-to middle-income country where no systematic screening systems exist in standard practice for HIVinfected youth. The more acute "life-threatening conditions" tend to draw medical attention away from the chronic, more subtle, but very important issues such as neurocognitive function. Neurocognitive function in youth is becoming increasingly important as more severe physical manifestations of HIV become less common with improved accessibility to ART. It may be that a pediatric system based on modified HAND criteria could be developed.
Limitations of this study include the small sample size for the HIV-negative youth and the use of these youth across a wide age range to serve as a z score reference for nonnormed test measures; this may have prevented enough statistical power for some of the neurocognitive comparisons. However, we recruited HIVnegative controls from the same community, schools, and clinics as the HIV-infected youth. While applying an adult-based classification to HIV-infected youth may not be ideal, we used a pediatric neurocognitive battery to determine functioning in the various domains. The HAND criteria could not detect higher rates of ND in the ART-naive slow progressors.
Despite the rollout of ART in South Africa, the recognition of ND in nearly 46% of the HIV-infected group is an indication that these problems remain important to identify and are probably largely underrecognized. While applying an adult-based classification to HIV-infected youth may not be ideal, this study has started the process of identifying a spectrum of ND in HIV-infected youth. This is especially important in adolescents whose ability to function in school will directly affect their economic/social trajectory as adults. Further research into the impact of ART on neurocognitive function and the improvement stability or progression of HAND utilizing larger prospective cohort studies in sub-Saharan Africa is needed.
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